RT Journal Article
SR Electronic
T1 A playbook for harmonization of standards for emergent viral pathogens
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.05.24314949
DO 10.1101/2024.10.05.24314949
A1 Suliman, Sara
A1 Fuchs, Sebastien
A1 Catoe, David
A1 Hansen, Loren
A1 Eveleigh, Deepa
A1 Crone, Michael A.
A1 Freemont, Paul S.
A1 Kammel, Martin
A1 Zeichhardt, Heinz
A1 Anfora, Andrew T.
A1 Garlick, Russell
A1 Almond, Neil
A1 Page, Mark
A1 Beck, Brian
A1 Wang, Hui
A1 Sharma, Karuna
A1 Pestano, Gary
A1 Vancann, Joannes
A1 Vandesompele, Jo
A1 Corner, Adam S
A1 Albrecht, Jeffrey
A1 Boles, Deborah J.
A1 Eisenberg, Marcia
A1 Harris, Ayla B.
A1 Krueger, Brian J.
A1 Suchanek, Amanda L.
A1 Urban, Thomas J.
A1 Williams, Jonathan D.
A1 Chain, Patrick
A1 Deshpande, Alina
A1 Hollander, Attelia
A1 Chalise, Sujata
A1 Walt, David R.
A1 Germer, Jeffrey
A1 Yao, Joseph D.
A1 Pritt, Bobbi S.
A1 Nolte, Frederick S.
A1 Košir, Alexandra Bogožalec
A1 Milavec, Mojca
A1 Cleveland, Megan H.
A1 Vallone, Peter M.
A1 Busby, Eloise J.
A1 Huggett, Jim F.
A1 O’Sullivan, Denise M.
A1 Marlowe, Elizabeth M.
A1 Pinsky, Benjamin A.
A1 Kealiher, Annaleise
A1 Lunshof, Jeantine E.
A1 Mason, Christopher E.
A1 Sninsky, John
A1 Tato, Cristina
A1 Mercer, Timothy
A1 White, Thomas J.
A1 Salit, Marc
YR 2024
UL http://medrxiv.org/content/early/2024/10/06/2024.10.05.24314949.abstract
AB Effective clinical and public health decision-making during a pandemic depends on reliable and interoperable clinical diagnostic test results. To ensure trustworthy outcomes, we need widely available and harmonized calibration standards on a shared scale. We present a ‘playbook’ for an inter-laboratory harmonization study that calibrates any available standards against a limited-availability standard issued by a global authority like the World Health Organization (WHO).Competing Interest StatementThe authors have declared no competing interest.Funding StatementSS is supported by grants from the Chan Zuckerberg Biohub, San Francisco and the National Institute of Allergy and Infectious Diseases (NIAID).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Use of clinical samples from patients with COVID-19 and controls has been approved by the IRB board of Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesRaw data and scripts are publicly available in this Github Repository: https://github.com/msalit/harmonization_dashboard. Processed data can be visualized using the Shiny app: https://msalit.shinyapps.io/RNAstudy/. https://github.com/msalit/harmonization_dashboard https://msalit.shinyapps.io/RNAstudy/